Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 35 entries
View as:

Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome?

Phase: N/A Priority: Normal
NCT ID: NCT01696344 Org: User:
Start: 05/31/12 End: 12/31/19 Due: 12/31/20

Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

Phase: N/A Priority: Normal
NCT ID: NCT02208102 Org: User:
Start: 07/31/14 End: 05/31/16 Due: 05/31/17

Immune Response Following COVID-19 Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT04736524 Org: User:
Start: 01/15/21 End: 03/31/22 Due: 03/31/23

Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation

Phase: N/A Priority: Normal
NCT ID: NCT01660100 Org: User:
Start: 07/31/12 End: 12/31/16 Due: 12/31/17

Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT01391091 Org: User:
Start: 12/31/10 End: 04/30/14 Due: 04/30/15

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

Phase: N/A Priority: Normal
NCT ID: NCT01006876 Org: User:
Start: 01/31/10 End: 04/30/14 Due: 04/30/15

Half-normal Saline in Atrial Fibrillation Ablation

Phase: N/A Priority: Normal
NCT ID: NCT03498586 Org: User:
Start: 05/02/18 End: 05/02/20 Due: 05/02/21

Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation

Phase: N/A Priority: Normal
NCT ID: NCT01362738 Org: User:
Start: 11/30/10 End: 11/30/16 Due: 11/30/17

Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)

Phase: N/A Priority: Normal
NCT ID: NCT01751607 Org: User:
Start: 12/31/12 End: 08/31/14 Due: 08/31/15

Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT01173796 Org: User:
Start: 03/31/10 End: 09/30/11 Due: 09/30/12

Impact of Anxiety on Cardiac Substrate Modification in Women With Atrial Fibrillation Undergoing Catheter Ablation

Phase: N/A Priority: Normal
NCT ID: NCT02547584 Org: User:
Start: 09/30/15 End: 07/31/22 Due: 07/31/23

Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation

Phase: N/A Priority: Normal
NCT ID: NCT01173809 Org: User:
Start: 10/31/10 End: 07/31/14 Due: 07/31/15

Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02219841 Org: User:
Start: 08/31/14 End: 12/31/22 Due: 12/31/23

Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02533843 Org: User:
Start: 04/30/14 End: 07/31/17 Due: 07/31/18

Natural History of COVID-19-Related Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT04830774 Org: User:
Start: 04/15/21 End: 12/31/23 Due: 12/31/24

PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation

Phase: N/A Priority: Normal
NCT ID: NCT01672346 Org: User:
Start: 05/31/13 End: 12/31/20 Due: 12/31/21

Pulmonary Vein Antrum Isolation (PVAI) Plus Scar Homogenization and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01672138 Org: User:
Start: 02/28/13 End: 12/31/20 Due: 12/31/21

Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter

Phase: N/A Priority: Normal
NCT ID: NCT01439386 Org: User:
Start: 09/30/11 End: 07/31/16 Due: 07/31/17

RF Applications for Residual LAA Leaks

Phase: N/A Priority: Normal
NCT ID: NCT04726943 Org: User:
Start: 02/01/21 End: 12/31/22 Due: 12/31/23

The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

Phase: N/A Priority: Normal
NCT ID: NCT01148914 Org: User:
Start: 06/30/10 End: 04/30/12 Due: 04/30/13

Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04372004 Org: User:
Start: 05/08/20 End: 06/30/21 Due: 06/30/22

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT04502017 Org: User:
Start: 08/05/20 End: 12/31/23 Due: 12/31/24

Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function

Phase: N/A Priority: Normal
NCT ID: NCT04506229 Org: User:
Start: 08/20/20 End: 09/30/21 Due: 09/30/22

Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT)

Phase: N/A Priority: Normal
NCT ID: NCT06488820 Org: User:
Start: 08/29/24 End: 04/04/25 Due: 04/04/26

Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation

Phase: N/A Priority: Normal
NCT ID: NCT04115436 Org: User:
Start: 10/01/19 End: 10/01/20 Due: 10/01/21